Scilex Holding (SCLXW) Common Equity (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Common Equity of -$254.1 million in Q1 2026, down 19.98% quarter-over-quarter from -$211.8 million in Q4 2025, and down 20.14% on a YoY basis from -$318.1 million in Q1 2025.

Scilex Holding (SCLXW) Common Equity (2020 - 2026) Analysis & Trends

Scilex Holding's Common Equity history runs 7 years deep, the most recent figure standing at -$254.1 million for Q1 2026.

  • In Q1 2026, Common Equity fell 20.14% year-over-year to -$254.1 million; the TTM figure through Mar 2026 stood at -$254.1 million (down 20.14% YoY), while the FY2025 annual figure was -$211.8 million, down 9.92% from the prior year.
  • Common Equity was -$254.1 million for Q1 2026 at Scilex Holding, down from -$211.8 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $36.2 million in Q4 2022 to a low of -$254.1 million in Q1 2026.
  • Historically, Common Equity has averaged -$170.7 million across 5 years, with a median of -$211.3 million in 2024.
  • Biggest YoY gain for Common Equity was 116.19% in 2022; the steepest drop was 2906.36% in 2022.
  • A 5-year view of Common Equity shows it stood at $36.2 million in 2022, then tumbled by 577.22% to -$172.9 million in 2023, then fell by 11.39% to -$192.6 million in 2024, then slipped by 9.92% to -$211.8 million in 2025, then dropped by 19.98% to -$254.1 million in 2026.
  • The last three Common Equity figures came in at -$254.1 million (Q1 2026), -$211.8 million (Q4 2025), and -$176.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 23.49 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 31.20 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 81.19 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -6.61 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 45.93 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 9.19 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 23.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 90.40 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 20.10 Bn
10 Scilex Holding - - 4.15 Mn -254.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -254.07 Mn
Dec 31, 2025 -211.75 Mn
Sep 30, 2025 -176.94 Mn
Jun 30, 2025 -248.99 Mn
Mar 31, 2025 -211.48 Mn
Dec 31, 2024 -192.64 Mn
Sep 30, 2024 -211.32 Mn
Jun 30, 2024 -214.69 Mn
Mar 31, 2024 -189.79 Mn
Dec 31, 2023 -172.94 Mn
Sep 30, 2023 -162.67 Mn
Jun 30, 2023 10.42 Mn
Mar 31, 2023 11.08 Mn
Dec 31, 2022 36.24 Mn
Sep 30, 2022 -229.40 Mn
Jun 30, 2022 -252.10 Mn
Mar 31, 2022 -231.57 Mn
Dec 31, 2021 -223.88 Mn
Sep 30, 2021 -9.83 Mn
Jun 30, 2021 -8.39 Mn